CCND1 and breast carcinoma: Thus, upregulation of cyclin-dependent kinase inhibitor p21(Cip1) and p27(Kip1), and downregulation of the CDK regulator cyclin D1, the proliferation and tumorigenesis of breast cancer cells would be inhibited [32].